TaiwanJ Pharmaceuticals Co (ROCO:6549) Common Stock: NT$801.22 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6549 TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
42 GF Score
Price NT$6.87
GF Value NT$12.09
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is TaiwanJ Pharmaceuticals Co Common Stock?

TaiwanJ Pharmaceuticals Co ROCO:6549 -1.58% 42 Common Stock is NT$801.22 Mil as of Dec. 2025. GuruFocus rates ROCO:6549 with a GF Score™ of 42/100 and a GF Value™ of NT$12.09 (Possible Value Trap). The stock has 2 warning signs investors should review.

TaiwanJ Pharmaceuticals Co's quarterly common stock stayed the same from Dec. 2024 (NT$801.22 Mil) to Jun. 2025 (NT$801.22 Mil) and stayed the same from Jun. 2025 (NT$801.22 Mil) to Dec. 2025 (NT$801.22 Mil).

TaiwanJ Pharmaceuticals Co's annual common stock increased from Dec. 2023 (NT$751.22 Mil) to Dec. 2024 (NT$801.22 Mil) but then stayed the same from Dec. 2024 (NT$801.22 Mil) to Dec. 2025 (NT$801.22 Mil).

TaiwanJ Pharmaceuticals Co Common Stock Historical Data

* Premium members only.

The historical data trend for TaiwanJ Pharmaceuticals Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TaiwanJ Pharmaceuticals Co Common Stock Chart

TaiwanJ Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 751.22 751.22 751.22 801.22 801.22

TaiwanJ Pharmaceuticals Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 751.22 751.22 801.22 801.22 801.22
ROCO:6549
42GF Score
TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TaiwanJ Pharmaceuticals Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$801.22 Mil mean?
TaiwanJ Pharmaceuticals Co (ROCO:6549) has a Common Stock of NT$801.22 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on TaiwanJ Pharmaceuticals Co and its competitors.
Is TaiwanJ Pharmaceuticals Co's Common Stock too high?
TaiwanJ Pharmaceuticals Co's current Common Stock is NT$801.22 Mil. Overall, TaiwanJ Pharmaceuticals Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiwanJ Pharmaceuticals Co's Common Stock compare to VRTX and REGN?
TaiwanJ Pharmaceuticals Co's Common Stock of NT$801.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on TaiwanJ Pharmaceuticals Co and its competitors. TaiwanJ Pharmaceuticals Co's current Common Stock is NT$801.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiwanJ Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co (ROCO:6549) is currently considered Possible Value Trap. The stock's GF Value™ is NT$12.09, compared to a current price of NT$6.87 — trading 43.2% below its estimated fair value. The current Common Stock is NT$801.22 Mil. TaiwanJ Pharmaceuticals Co's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For TaiwanJ Pharmaceuticals Co (ROCO:6549), the current Common Stock is NT$801.22 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TaiwanJ Pharmaceuticals Co (ROCO:6549) Overvalued in 2026?

Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$6.87 is trading 43.2% below its estimated GF Value™ of NT$12.09. GuruFocus considers TaiwanJ Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for ROCO:6549:

  • Common Stock: NT$801.22 Mil
  • GF Value™: NT$12.09 vs. price of NT$6.87 (43.2% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TaiwanJ Pharmaceuticals Co Business Description

Address No. 6-1, Shengyi Road, 3F-4, Section 2, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
42GF Score

Get the complete analysis for ROCO:6549

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.87
Price
NT$12.09
GF Value